Movicol Junior Nøytral Smak

Macrogol 3350, the active ingredient in Movicol Junior Nøytral Smak, is an osmotic laxative presented as an oral solution for oral use. It treats constipation in children by increasing water content in the intestinal lumen. GNH USA supplies Movicol Junior Nøytral Smak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Junior Nøytral Smak, an osmotic laxative, is used to manage constipation in the pediatric population.

Constipation: relieves infrequent, hard stools and improves stool frequency in children. Functional constipation: softens stool consistency and eases passage. Encopresis secondary to constipation: helps normalize bowel movements and reduce stool withholding.

Common Side Effects: - Abdominal bloating: mild distension of the abdomen. - Flatulence: increased intestinal gas. - Nausea: feeling of queasiness. - Mild abdominal pain: discomfort in the stomach area. - Diarrhoea: loose, watery stools. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium or potassium levels. - Severe dehydration: marked loss of body fluids. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Severe abdominal pain: intense, persistent pain. - Rectal bleeding: presence of blood in stool. - Acute kidney injury: sudden loss of kidney function.

Before prescribing Movicol Junior Nøytral Smak, consider the following precautions: - Electrolyte monitoring: check serum electrolytes in patients with renal impairment or on diuretics. - Fluid balance: ensure adequate hydration to prevent dehydration. - Renal function: use with caution in children with reduced kidney function. - Age considerations: dosage may need adjustment for very young children. - Pregnancy and lactation: consult a prescriber before use in pregnant or breastfeeding individuals. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Movicol Junior Nøytral Smak may interact with other medicines as follows:

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of hyperkalaemia. - Other osmotic laxatives: additive electrolyte disturbances. - Lithium: increased lithium serum concentrations. - ACE inhibitors: potential for elevated potassium levels. - Anticholinergic agents: may reduce laxative efficacy.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes and renal function. - Renin‑angiotensin system blockers: observe potassium balance.